XORTX Therapeutics Inc.
XRTX
$0.87
-$0.1026-10.55%
| Weiss Ratings | XRTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | XRTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | XRTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.14 | |||
| Price History | XRTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -11.21% | |||
| 30-Day Total Return | -6.47% | |||
| 60-Day Total Return | -26.58% | |||
| 90-Day Total Return | -44.06% | |||
| Year to Date Total Return | -25.63% | |||
| 1-Year Total Return | -80.45% | |||
| 2-Year Total Return | -81.73% | |||
| 3-Year Total Return | -92.94% | |||
| 5-Year Total Return | -91.61% | |||
| 52-Week High % Change | -83.26% | |||
| 52-Week Low % Change | 18.61% | |||
| Price | XRTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $5.81 | |||
| 52-Week Low Price | $0.82 | |||
| 52-Week Low Price (Date) | Feb 21, 2025 | |||
| 52-Week High Price (Date) | Mar 15, 2024 | |||
| Valuation | XRTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 3.31M | |||
| Enterprise Value | 1.21M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.04 | |||
| Earnings Per Share Growth | -98.92% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | 1.32 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.87 | |||
| Enterprise Value/EBITDA (TTM) | -0.44 | |||
| Enterprise Value/EBIT | -0.43 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | XRTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 2.90M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | XRTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 403 455 7727 | |||
| Address | 3710 – 33rd Street NW Alberta Beach, AB T2L 2M1 | |||
| Website | www.xortx.com | |||
| Country | Canada | |||
| Year Founded | -- | |||
| Profitability | XRTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | XRTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -33.81% | |||
| Return on Equity | -- | |||
| Income Statement | XRTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -2.76M | |||
| EBIT (TTM) | -2.84M | |||
| Net Income (TTM) | -736.60K | |||
| Net Income Avl. to Common (TTM) | -736.60K | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | 55.98% | |||
| EPS Diluted (TTM) | -0.04 | |||
| EPS Diluted Growth (Q YOY) | 69.82% | |||
| Balance Sheet | XRTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 2.30M | |||
| Cash Per Share (Q) | $0.79 | |||
| Total Current Assets (Q) | 2.41M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 2.13M | |||
| Current Ratio (Q) | 6.216 | |||
| Book Value Per Share (Q) | $0.73 | |||
| Total Assets (Q) | 3.85M | |||
| Total Current Liabilities (Q) | 387.80K | |||
| Total Debt (Q) | 61.50K | |||
| Total Liabilities (Q) | 1.72M | |||
| Total Common Equity (Q) | 2.13M | |||
| Cash Flow | XRTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -44.70K | |||
| Cash from Financing (TTM) | 1.36M | |||
| Net Change in Cash (TTM) | -2.77M | |||
| Levered Free Cash Flow (TTM) | -1.71M | |||
| Cash from Operations (TTM) | -4.09M | |||
